cancer clinical trials in omaha, NE

Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

Alegant Health Cancer Center at Bergan Mercy Medical Center
Omaha, Nebraska 68124

Lung Cancer

An Investigational Drug, PD 0332991, Is Being Studied In Combination With Velcade And Dexamethasone In Patients With Multiple Myeloma. Patients Must Have Received Prior Treatment For Multiple Myeloma.

Pfizer Investigational Site
Omaha, Nebraska 68198

Multiple Myeloma

Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer

Methodist Estabrook Cancer Center
Omaha, Nebraska 68114-4199

Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer

Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors

Methodist Estabrook Cancer Center

Trial Locations
Methodist Estabrook Cancer Center
Nebraska Medical Center

Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

CCOP - Missouri Valley Cancer Consortium

Trial Locations
CCOP - Missouri Valley Cancer Consortium
Methodist Estabrook Cancer Center
Immanuel Medical Center
Creighton University Medical Center
Alegant Health Cancer Center at Bergan Mercy Medical Center
Lakeside Hospital
Nebraska Medical Center

Prostate Cancer

Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor

Alegent Health Immanuel Medical Center

Trial Locations
Alegent Health Immanuel Medical Center
Alegent Health Bergan Mercy Medical Center
Missouri Valley Cancer Consortium CCOP
Alegent Health Lakeside Hospital

Neuroendocrine Carcinoma

Cardiac Magnetic Resonance Imaging in Patients With Newly Diagnosed Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin

UNMC Eppley Cancer Center at the University of Nebraska Medical Center
Omaha, Nebraska 68198-7680

Cardiac Toxicity, Chemotherapeutic Agent Toxicity, Lymphoma

Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)

Pfizer Investigational Site
Omaha, Nebraska 68198

Adenomatous Polyposis Coli

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

University of Nebraska Medical Center

Trial Locations
University of Nebraska Medical Center
Methodist Estabrook Cancer Center
Creighton University Medical Center
Alegent Health Immanuel Medical Center
Alegent Health Bergan Mercy Medical Center
Missouri Valley Cancer Consortium CCOP
Alegent Health Lakeside Hospital

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary

Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab

Creighton University Medical Center

Trial Locations
Creighton University Medical Center
Alegant Health Cancer Center at Bergan Mercy Medical Center

Colorectal Cancer

Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer

Creighton University Medical Center

Trial Locations
Creighton University Medical Center
Alegent Health Immanuel Medical Center
Alegent Health Bergan Mercy Medical Center
Missouri Valley Cancer Consortium CCOP

Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer

Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma

Stereotactic Radiation Therapy in Treating Patients With Advanced Liver Cancer

UNMC Eppley Cancer Center at the University of Nebraska Medical Center
Omaha, Nebraska 68198-7680

Liver Cancer

Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib

Nebraska Methodist Cancer Center
Omaha, Nebraska 68114

Non-Small Cell Lung Cancer

Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer

Nebraska Medical Center
Omaha, Nebraska 68198

Colorectal Cancer